Dr Shaw speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about results from the JAVELIN 101 trial of avelumab in combination with either criztonib or lurlatinib She reports low efficacy and limiting toxicities...
Original Article: Avelumab in combinations for lung cancer and update from ALEX study